Home > Cardiology > TAVR likely beneficial in low-risk patients with bicuspid valve stenosis

TAVR likely beneficial in low-risk patients with bicuspid valve stenosis


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
JAMA Cardiology
Reuters Health - 17/10/2020 - Low-surgical risk patients with bicuspid aortic valve stenosis experienced favorable 30-day results with transcatheter aortic valve replacement (TAVR) in a single-arm trial. "The findings of this prospective study further support retrospective transcatheter valve therapy data which have shown that TAVR in patients with bicuspid aortic valve disease yields favorable results," Dr. John Forrest of Yale University School of Medicine told Reuters Health by email. "In this study, 10% of patients had a Sievers Type 0 bicuspid valve and the remaining had a Type I. Notably, both groups did very well with respect to valve performance, hemodynamics, and paravalvular leak." As reported in JAMA Cardiology, Dr. Forrest and colleagues analyzed 30-day outcome data from the Low-Risk Bicuspid Study, which has a planned follow-up of 10 years. Eligible patients had severe bicuspid aortic valve stenosis and met American Heart Association/American College of...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on